4147 Development of A National Guideline On Skin Testing and Immunotherapy

Wednesday, 7 December 2011: 13:30 - 00:00
Bacalar (Cancún Center)

Désirée Larenas Linnemann, MD, FAAAAI, Dist, Int, FACAAI , Allergy, Hospital Médica Sur, Mexico DF, Mexico

José Antonio Ortega Martell, MD , Medicina, Universidad autónoma del Estado de Hidalgo, Pachuca, Mexico

Blanca del Rio, MD , Pediatric Allergy and Clinical Immunology, Hospital Infantil de Mexico Federico Gomez, Mexico City, Mexico

Noel Rodriguez-Perez, M.D. , State Autonomous University of Tamaulipas, H. Matamoros, TAM., Mexico

Alfredo Arias-Cruz, MD , Allergy and Clinical Immunology, University Hospital UANL, Monterrey, Mexico

Alan Estrada, MD , Private practice, Playa del Carmen, Mexico

Background: Several international guidelines exist on allergen immunotherapy (AIT) –e.g. American, European, British, Spanish, Italian- but local conditions that reign in each country limit their applicability. We present the steps we followed to develop a National Guideline on AIT, taking into account local legislation, extracts available, costs and patient preference.

Methods: firstly a Nation-wide survey on the practice of skin testing and AIT was undertaken among all members of Mexican Allergist Societies. Secondly, based on the replies obtained with the survey clinical questions were formulated on critical points and issues susceptible for improvement, as diagnosed by the survey. Thirdly, all six Regional Allergist Societies were visited to obtain the opinion of their members on the clinical questions concerning how immunotherapy could best be practiced under local Mexican conditions. This led to the Consensed experience. Fourthly, six experts looked for the replies to the clinical questions reviewing the literature and assigning quality of evidence to the articles on the specific issues treated by each clinical question.

Results: To develop the final document the GRADE approach was used. For each clinical question both, knowledge from the local consensed experience and the evidence-based replies were taken into account, as well as cost, patient preference and safety to make a set of recommendations and suggestions on the most crucial aspects of skin testing and AIT. Forming centers of allergists in Mexico corrected the final draft. The final document came out as the January issue of Revista Mexicana Alergia and was presented by the authors in a National Course on Immunotherapy (May 2011), with –apart from the lectures- a more workshop-like part to allow for practical exercising and discussion. The updated questions on allergen immunotherapy for the final board exam are based on the Guideline. Allergy-residents developed a slide-show. In 2012 Regional Allergist Societies shall be visited again.

Conclusions: We present a democratic way of how a National Guideline can be developed, supported by evidence-based medicine and local experience in a country where little is legislated on this respect and quality improvement has to be stimulated by the professional community. We show how implementation can be enhanced.